Defective Drug News

Utah Bill to Allow MDs to Dispense Drugs

A controversial bill in Utah has passed both houses of the state legislature and is expected to be signed by … Full Story

Posted in: Defective Drug News

FDA Comments on Yaz Blood Clot Risk

The U.S. Food and Drug Administration (FDA) announced April 10 it will be adding information on an increased risk of … Full Story

Posted in: Defective Drug News, Yasmin, Yaz

Tagged: , , , ,

FDA Revises Celexa Label

The U.S. Food and Drug Administration issued a drug safety communication March 28 to clarify the dosing and warnings recommended … Full Story

Posted in: Celexa

Tagged: ,

Nationwide Recall of Cyanocobalamin Injection

American Regent announced it is voluntarily recalling three lots of an injectable solution, Cyanocobalamin, given to certain groups of people … Full Story

Posted in: Defective Drug News

Tagged: ,

Pradaxa Price to Drop

Boehringer Ingelheim, the manufacturer of the anticoagulant Pradaxa®, has announced it plans to reduce the price of the medication by … Full Story

Posted in: Pradaxa

Tagged: ,

Rheumatoid Arthritis Patients, Risk of Death

According to a Canadian study, patients with rheumatoid arthritis who stop taking their statin medications may be at an increased … Full Story

Posted in: Crestor

Tagged: ,

Pradaxa Lawsuit Filed for Internal Bleeding

A couple in Lafayette, Louisiana reportedly filed a Pradaxa® lawsuit earlier this month for serious bleeding problems and the subsequent … Full Story

Posted in: Pradaxa

Tagged: ,

Generic Drug Maker Watson to Buy Actavis

According to the Wall Street Journal, the generic drug maker Watson Pharmaceuticals Inc. (WPI) is getting closer to purchasing competing … Full Story

Posted in: Defective Drug News

Tagged: ,

Actos Maker Violates False Claims Act

A whistleblower filed a lawsuit alleging a unit of Takeda Pharmaceutical Co. failed to provide truthful reports of hundreds of … Full Story

Posted in: Actos

Tagged: ,

FDA Approves First Generic Lexapro

The first generic version of Lexapro® (escitalopram) won approval March 14 from the U.S. Food and Drug Administration (FDA). The … Full Story

Posted in: Lexapro

Tagged: , ,

Free Consultation Use this form to request a free consultation with a qualified attorney near you.

*

Note: The use of the Internet for communications with the firm will not establish an attorney-client relationship and messages containing confidential or time-sensitive information should not be sent. I agree that submitting this form does not create an attorney-client relationship and that the information I am providing may be used to check for conflicts of interest to determine if the firm can assist me with my legal inquiry. I Agree:*

ATTORNEY ADVERTISING
Flood Law Group, LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private
FREE